BOT:ASX
Botanix Pharmaceuticals Ltd
AU$0.0080
0.00%
(0.00) 1D
ኖቬም 20, 4:10:06 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Mkt. cap
22.10 ሚ
Avg. vol.
11.19 ሚ
Volume
0.00
52-wk high
AU$0.15
52-wk low
AU$0.01
EPS
-AU$0.03
Shares outstanding
2.76 ቢ
No. of employees
11
Mkt. cap
22.10 ሚ
Avg. vol.
11.19 ሚ
Volume
0.00
52-wk high
AU$0.15
52-wk low
AU$0.01
EPS
-AU$0.03
Shares outstanding
2.76 ቢ
No. of employees
11
News stories
From web sources and news partners
Beinsure
·
ከ14 ደቂቃዎች በፊት
Nasdaq Composite record highs in 2026 raise concerns over AI stock valuations
The Motley Fool
·
ከ15 ሰዓቶች በፊት
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
24/7 Wall St.
·
ከ4 ሰዓቶች በፊት
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Yahoo Finance
·
ከ1 ቀን በፊት
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com